Routine NHS access to spinal muscular atrophy treatments offers new hope for patients and families
Posted:
SMA is a rare, inherited condition that causes progressive muscle weakness, affecting movement, breathing and swallowing. People living with spinal muscular atrophy (SMA) in England are set to gain routine access to two potentially life-changing treatments, following our publication of final draft guidance today.
Reed Jobs is keen for his $1bn venture capital fund Yosemite to make a difference.
The 34-year-old runs an oncology-focused venture capital fund that manages more than $1bn in assets, and is in the UK looking for investment opportunities.
Read…
Insomnia affected more than one third of patients with irritable bowel syndrome (IBS) and was primarily driven by psychological distress and somatic comorbidities rather than gastrointestinal symptom severity alone. Patients with IBS and insomnia experienced more severe somatic and psychological symptoms and had impaired quality…
Attendees
Sponsors and Exhibitors
Contact us